DosentRx received grant from the “Digital Israel” Project

DosentRx Ltd., in partnership with the Israeli Ministry of Health, received a grant from the Israel Innovation Authority and the “Digital Israel” Fund as a ‘Strategically Important Program’ to the Israeli Healthcare System. The ReX system was recognized as a unique technological platform with the potential to make a significant impact on public health in Israel and beyond. The grant allocated to DosentRx supports a series of clinical pilots across Israel wherein ReX will be evaluated towards integration into the Israeli health system.       

DosentRx (www.dosentrx.com) has received a grant from the “Digital Israel” Project via the Israel Innovation Authority to further develop its ReX system and evaluate it in a series of clinical pilots across Israel. ReX is a digital health system that empowers patients to achieve 100% adherence to their medication therapy, thereby optimizing their clinical outcome. The Israel Innovation Authority (IIA) is the technology investment arm of the Israeli government. The IIA promotes and supports R&D preserving Israel’s position at the forefront of global innovation. The “Digital Israel” Project, is a national digital initiative designed to leverage Israeli innovation. The IIA recognized the ReX system as a unique technological platform with the potential to make a significant impact on public health in Israel and beyond. The grant allocated to DosentRx supports a series of clinical pilots across Israel wherein ReX will be evaluated towards integration into the Israeli health system.

Alan Paz, Founder of DosentRx, comments: “The mission of DosentRx is to empower patients to maximize the outcome of their medication treatment. ReX is designed to prevent errors, to remind patients when it’s time to take a pill, to help manage their side effects and to provide relevant personalized information to improve their medication consumption and health. We are proud of this vote of confidence from the Israeli Ministry of Health and the Israel Innovation Authority in the importance of ReX.”

About DosentRx Ltd.

DosentRx focuses on personalized digital health solutions. The company is head-quartered in Har Tuv Israel, with a wholly-owned subsidiary located at Houston, Texas. DosentRx developed ReX, an integrated digital health system. ReX empowers patients to achieve 100% adherence to their medication therapy while monitoring patient state of health through system-level surveys. The combination of enhanced adherence and wellness monitoring enables clinical outcomes to be optimized. ReX is intended for use with medication, where strict adherence is crucial to ameliorate the patient’s condition. ReX safeguards patients from drug overdose or abuse, giving piece of mind to their loved ones.